Atai Life Sciences N.V.

NASDAQ: ATAI · Real-Time Price · USD
3.88
-0.13 (-3.24%)
At close: Aug 15, 2025, 3:59 PM
3.88
-0.13%
After-hours: Aug 15, 2025, 07:51 PM EDT

Atai Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
308K 314K 233K 20.38M
Cost of Revenue
473K n/a 168K 47K
Gross Profit
1.55M 314K 65K 20.33M
Operating Income
-102.69M -125.47M -144.79M -135.81M
Interest Income
778K 1.85M 548K 205K
Pretax Income
-148.41M -39.29M -135.18M -136.6M
Net Income
-149.27M -40.22M -141.41M -132.61M
Selling & General & Admin
47.54M 63.58M 70.35M 92.75M
Research & Development
55.45M 62.2M 74.31M 47.96M
Other Expenses
n/a n/a n/a -796K
Operating Expenses
103M 125.78M 144.66M 140.7M
Interest Expense
3.12M 2.66M 923K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
103M 125.78M 144.66M 140.7M
Income Tax Expense
-356K 1.02M 6.23M -3.99M
Shares Outstanding (Basic)
160.16M 158.83M 155.72M 160.68M
Shares Outstanding (Diluted)
160.16M 158.83M 155.72M 160.68M
EPS (Basic)
-0.93 -0.25 -0.91 -0.83
EPS (Diluted)
-0.93 -0.25 -0.91 -0.83
EBITDA
-145.33M -36.31M -135.01M -120.28M
EBIT
-145.28M -36.63M -135.18M -120.33M
Depreciation & Amortization
473K 319K 168K 47K